TOPRELOC-XL metoprolol succinate 23.75 mg modified release tablet bottle Australia - inglese - Department of Health (Therapeutic Goods Administration)

topreloc-xl metoprolol succinate 23.75 mg modified release tablet bottle

pharmacor pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: triethyl citrate; macrogol 6000; croscarmellose sodium; povidone; sodium stearylfumarate; purified talc; silicon dioxide; silicified microcrystalline cellulose; methacrylic acid copolymer; ethylcellulose; microcrystalline cellulose; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

TOBETA-XL metoprolol succinate 23.75 mg modified release tablet blister pack Australia - inglese - Department of Health (Therapeutic Goods Administration)

tobeta-xl metoprolol succinate 23.75 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: purified talc; macrogol 6000; microcrystalline cellulose; povidone; silicon dioxide; triethyl citrate; sodium stearylfumarate; croscarmellose sodium; silicified microcrystalline cellulose; methacrylic acid copolymer; ethylcellulose; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

TOPRELOC-XL metoprolol succinate 47.5 mg modified release tablet blister pack Australia - inglese - Department of Health (Therapeutic Goods Administration)

topreloc-xl metoprolol succinate 47.5 mg modified release tablet blister pack

pharmacor pty ltd - metoprolol succinate, quantity: 47.5 mg - tablet, modified release - excipient ingredients: triethyl citrate; croscarmellose sodium; microcrystalline cellulose; ethylcellulose; silicified microcrystalline cellulose; macrogol 6000; silicon dioxide; povidone; purified talc; sodium stearylfumarate; methacrylic acid copolymer; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

TOPRELOC-XL metoprolol succinate 190 mg modified release tablet blister pack Australia - inglese - Department of Health (Therapeutic Goods Administration)

topreloc-xl metoprolol succinate 190 mg modified release tablet blister pack

pharmacor pty ltd - metoprolol succinate, quantity: 190 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; silicified microcrystalline cellulose; triethyl citrate; macrogol 6000; silicon dioxide; croscarmellose sodium; purified talc; ethylcellulose; povidone; sodium stearylfumarate; methacrylic acid copolymer; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

TOBETA-XL metoprolol succinate 95 mg modified release tablet blister pack Australia - inglese - Department of Health (Therapeutic Goods Administration)

tobeta-xl metoprolol succinate 95 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - metoprolol succinate, quantity: 95 mg - tablet, modified release - excipient ingredients: silicified microcrystalline cellulose; purified talc; macrogol 6000; methacrylic acid copolymer; microcrystalline cellulose; povidone; croscarmellose sodium; ethylcellulose; silicon dioxide; triethyl citrate; sodium stearylfumarate; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

TOBETA-XL metoprolol succinate 190 mg modified release tablet bottle Australia - inglese - Department of Health (Therapeutic Goods Administration)

tobeta-xl metoprolol succinate 190 mg modified release tablet bottle

pharmacor pty ltd - metoprolol succinate, quantity: 190 mg - tablet, modified release - excipient ingredients: ethylcellulose; povidone; silicified microcrystalline cellulose; sodium stearylfumarate; methacrylic acid copolymer; triethyl citrate; microcrystalline cellulose; croscarmellose sodium; silicon dioxide; macrogol 6000; purified talc; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Nobilis IB Primo QX Freeze-dried Powder for Injection (Oculo-Nasal/Aerosol) Filippine - inglese - FDA (Food And Drug Administration)

nobilis ib primo qx freeze-dried powder for injection (oculo-nasal/aerosol)

n/a; importer: msd animal health (phils.), inc.; distributor: n/a - live attenuated infectious bronchitis (ib) virus vaccine (vet.) - freeze-dried powder for injection (oculo-nasal/aerosol) - formulation: each dose of contains: infectious bronchitis (ib) virus (d388 strain)->4 log10 eid50 eid-embryo infective dose

Cevac BI L Lyophilisate For Oculonasal Suspension Kenya - inglese - Pharmacy and Poisons Board

cevac bi l lyophilisate for oculonasal suspension

ceva santa animale 10 avenue de la ballastiere 33500 libourne - - avian infectious bronchi - lyophilisate for oculonasal suspension - infectious bronchitis virus massachusetts type… - immunologicals for domestic fowl: live viral

Cevac NEW L Lyophilisate For Oculonasal Suspension Kenya - inglese - Pharmacy and Poisons Board

cevac new l lyophilisate for oculonasal suspension

ceva sante animale 10 avenue de la ballastiere 33500 libourne france - newcastle disease virus strain lasota - lyophilisate for oculonasal suspension - newcastle disease virus strain lasota min 5.5… - immunologicals for domestic fowl: live viral

Cevac UNI L Lyophilisate For Oculonasal Suspension Kenya - inglese - Pharmacy and Poisons Board

cevac uni l lyophilisate for oculonasal suspension

ceva sante animale 10 avenue de la ballastiere 33500 libourne france - newcastle disease - lyophilisate for oculonasal suspension - newcastle disease virus strain b1 min 5.5 log10… - immunologicals for domestic fowl: live viral